Literature DB >> 17901550

Electrophilic cyclopentenone isoprostanes in neurodegeneration.

Erik S Musiek1, Bethann McLaughlin, Jason D Morrow.   

Abstract

Although oxidative stress has been implicated in the pathogenesis of numerous neurodegenerative conditions, the precise mechanisms by which reactive oxygen species (ROS) induce neuronal death are still being explored. The generation of reactive lipid peroxidation products is thought to contribute to ROS neurotoxicity. Isoprostanes (IsoPs), prostaglandin-like molecules formed in vivo via the ROS-mediated oxidation of arachidonic acid, have been previously demonstrated to be formed in increased amounts in the brains of patients with various neurodegenerative diseases. Recently, we have identified a new class of IsoPs, known as A(2)- and J(2)-IsoPs or cyclopentenone IsoPs, which are highly reactive electrophiles and form adducts with thiol-containing molecules, including cysteine residues in proteins and glutathione. Cyclopentenone IsoPs are favored products of the IsoP pathway in the brain and are formed abundantly after oxidant injury. These compounds also potently induce neuronal apoptosis by a mechanism which involves glutathione depletion, ROS generation, and activation of several redox-sensitive pathways that overlap with those involved in other forms of oxidative neurodegeneration. Cyclopentenone IsoPs also enhance neurodegeneration caused by other insults at biologically relevant concentrations. These data are reviewed, whereas new data demonstrating the neurotoxicity of J-ring IsoPs and a discussion of the possible role of cyclopentenone IsoPs as contributors to neurodegeneration are presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901550      PMCID: PMC2881560          DOI: 10.1007/s12031-007-0042-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  63 in total

1.  Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease.

Authors:  T J Montine; M F Beal; D Robertson; M E Cudkowicz; I Biaggioni; H O'Donnell; W E Zackert; L J Roberts; J D Morrow
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

2.  Characterization of 8-epiprostaglandin F2alpha as a marker of amyloid beta-peptide-induced oxidative damage.

Authors:  R J Mark; K S Fuson; P C May
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

3.  4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites.

Authors:  M J Picklo; V Amarnath; J O McIntyre; D G Graham; T J Montine
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

4.  Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

Authors:  G Perry; H Roder; A Nunomura; A Takeda; A L Friedlich; X Zhu; A K Raina; N Holbrook; S L Siedlak; P L Harris; M A Smith
Journal:  Neuroreport       Date:  1999-08-02       Impact factor: 1.837

5.  Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway.

Authors:  Y Chen; J D Morrow; L J Roberts
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

6.  The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

Authors:  M D Neely; K R Sidell; D G Graham; T J Montine
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

7.  Increased CSF F2-isoprostane concentration in probable AD.

Authors:  T J Montine; M F Beal; M E Cudkowicz; H O'Donnell; R A Margolin; L McFarland; A F Bachrach; W E Zackert; L J Roberts; J D Morrow
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

8.  Evidence for the formation of a novel cyclopentenone isoprostane, 15-A2t-isoprostane (8-iso-prostaglandin A2) in vivo.

Authors:  Y Chen; W E Zackert; L J Roberts; J D Morrow
Journal:  Biochim Biophys Acta       Date:  1999-01-04

9.  Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity.

Authors:  C Xie; M A Lovell; W R Markesbery
Journal:  Free Radic Biol Med       Date:  1998-11-15       Impact factor: 7.376

10.  Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

Authors:  D Praticò; V MY Lee; J Q Trojanowski; J Rokach; G A Fitzgerald
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

View more
  8 in total

Review 1.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 2.  Isoprostane generation and function.

Authors:  Ginger L Milne; Huiyong Yin; Klarissa D Hardy; Sean S Davies; L Jackson Roberts
Journal:  Chem Rev       Date:  2011-08-18       Impact factor: 60.622

3.  The Link Between 15-F2t-Isoprostane Activity and Acute Bovine Endothelial Inflammation Remains Elusive.

Authors:  Ashley K Putman; Lorraine M Sordillo; G Andres Contreras
Journal:  Front Vet Sci       Date:  2022-04-29

4.  Comparison of three oxidative stress biomarkers in a sample of healthy adults.

Authors:  Joanne L Watters; Jessie A Satia; Kerry-Ann da Costa; Gunnar Boysen; Leonard B Collins; Jason D Morrow; Ginger L Milne; James A Swenberg
Journal:  Biomarkers       Date:  2009-12       Impact factor: 2.658

5.  Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain.

Authors:  James Stringari; Adriana K C Nunes; Jeferson L Franco; Denise Bohrer; Solange C Garcia; Alcir L Dafre; Dejan Milatovic; Diogo O Souza; João B T Rocha; Michael Aschner; Marcelo Farina
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

6.  Alteration of isocitrate dehydrogenase following acute ischemic injury as a means to improve cellular energetic status in neuroadaptation.

Authors:  Kimberly N Grelli; Amy M Palubinsky; A Cozette Kale; Britney N Lizama-Manibusan; Jeannette N Stankowski; Ginger L Milne; Robert Singer; Bethann McLaughlin
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

7.  Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress.

Authors:  David A Andersson; Clive Gentry; Sian Moss; Stuart Bevan
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

Review 8.  Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.

Authors:  Bohae Rachel Lee; May Hnin Paing; Neelam Sharma-Walia
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.